Literature DB >> 11404380

Tissue distribution of CD6 and CD6 ligand in cattle: expression of the CD6 ligand (CD166) in the autonomic nervous system of cattle and the human.

A Konno1, J S Ahn, H Kitamura, M J Hamilton, J A Gebe, A Aruffo, W C Davis.   

Abstract

We studied the tissue distribution of CD6(+) lymphocytes and cells expressing the CD6 ligand (also known as activated leukocyte cell adhesion molecule CD166) in calves by immunohistochemistry using an anti-bovine CD6 monoclonal antibody (mAb), a human CD6 (huCD6)-immunoglobulin G1 fusion protein (huCD6-Ig), and an anti-human CD166 (anti-huCD166) mAb. The huCD6-Ig and anti-huCD166 mAb bound to the sympathetic and parasympathetic nerve fibers but not to myelinated nerve fibers in the spinal nerve. Studies with human tissue using the anti-huCD166 mAb yielded identical patterns of labeling. Dense accumulations of CD6(+) lymphocytes were present in areas of the thymuses and spleens of calves, in areas innervated by huCD6-Ig(+) nerves. The cDNAs encoding the bovine CD166 and CD6 were isolated from the sympathetic ganglion and spleen, respectively. Predicted amino acid residues that are important for human and mouse CD6-CD166 binding were also conserved in bovine CD6 and CD166. Bovine CD166 transcripts were detected by reverse transcriptase-PCR in all the tissues that bound huCD6-Ig. These results show that the bovine orthologue of CD166 was constitutively expressed in the autonomic nervous systems of cattle and suggest that CD6(+) lymphocytes adhere to CD166(+) autonomic nerve terminals via CD6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404380

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Allele substitution and dominance effects of CD166/ALCAM gene polymorphisms for endoparasite resistance and test-day traits in a small cattle population using logistic regression analyses.

Authors:  Katharina May; Christina Weimann; Carsten Scheper; Christina Strube; Sven König
Journal:  Mamm Genome       Date:  2019-10-24       Impact factor: 2.957

2.  Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.

Authors:  Judy A King; Fang Tan; Flaubert Mbeunkui; Zachariah Chambers; Sarah Cantrell; Hairu Chen; Diego Alvarez; Lalita A Shevde; Solomon F Ofori-Acquah
Journal:  Mol Cancer       Date:  2010-10-07       Impact factor: 27.401

3.  Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Authors:  Ruby Alonso-Ramirez; Séverine Loisel; Caroline Buors; Jacques-Olivier Pers; Enrique Montero; Pierre Youinou; Yves Renaudineau
Journal:  Arthritis       Date:  2011-02-10

4.  Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.

Authors:  Esther Carrasco; Cristina Escoda-Ferran; Núria Climent; Cristina Miró-Julià; Inês T Simões; Mario Martínez-Florensa; Adelaida Sarukhan; Esther Carreras; Francisco Lozano
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 5.  Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.

Authors:  María Velasco-de Andrés; Sergi Casadó-Llombart; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Fernando Aranda
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

6.  Proteomic Characterization of Host-Pathogen Interactions during Bovine Trophoblast Cell Line Infection by Neospora caninum.

Authors:  Javier Regidor-Cerrillo; Dong Xia; Laura Jiménez-Pelayo; Marta García-Sánchez; Esther Collantes-Fernández; Nadine Randle; Jonathan Wastling; Luis-Miguel Ortega-Mora; Pilar Horcajo
Journal:  Pathogens       Date:  2020-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.